X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (38171) 38171
Newsletter (2257) 2257
Newspaper Article (482) 482
Magazine Article (310) 310
Book Chapter (173) 173
Dissertation (122) 122
Publication (109) 109
Transcript (63) 63
Conference Proceeding (25) 25
Book / eBook (13) 13
Streaming Video (13) 13
Reference (11) 11
Web Resource (11) 11
Book Review (9) 9
Government Document (3) 3
Journal / eJournal (1) 1
Pamphlet (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
warfarin (26598) 26598
humans (25680) 25680
male (13550) 13550
female (13027) 13027
aged (9889) 9889
warfarin - therapeutic use (9035) 9035
anticoagulants - therapeutic use (8915) 8915
middle aged (8896) 8896
anticoagulants (8219) 8219
atrial fibrillation (7510) 7510
stroke (6311) 6311
anticoagulants - adverse effects (5822) 5822
anticoagulants - administration & dosage (5722) 5722
adult (5587) 5587
risk factors (5554) 5554
warfarin - adverse effects (5402) 5402
cardiac & cardiovascular systems (5217) 5217
warfarin - administration & dosage (5160) 5160
anticoagulation (4365) 4365
aged, 80 and over (4269) 4269
prevention (4201) 4201
pharmacology & pharmacy (4076) 4076
medicine, general & internal (4029) 4029
atrial fibrillation - drug therapy (3900) 3900
peripheral vascular disease (3807) 3807
treatment outcome (3782) 3782
risk (3751) 3751
hematology (3743) 3743
therapy (3735) 3735
international normalized ratio (3489) 3489
thromboembolism (3455) 3455
dabigatran (3358) 3358
administration, oral (3304) 3304
management (3241) 3241
research (3213) 3213
atrial fibrillation - complications (3038) 3038
stroke - prevention & control (3000) 3000
aspirin (2983) 2983
hemorrhage - chemically induced (2928) 2928
care and treatment (2846) 2846
retrospective studies (2804) 2804
thrombosis (2766) 2766
atrial-fibrillation (2747) 2747
animals (2507) 2507
rivaroxaban (2502) 2502
analysis (2491) 2491
drug therapy (2373) 2373
abridged index medicus (2299) 2299
surgery (2239) 2239
time factors (2196) 2196
drug interactions (2194) 2194
warfarin - pharmacology (2113) 2113
hemorrhage (2077) 2077
mortality (1980) 1980
venous thromboembolism (1935) 1935
dosage and administration (1922) 1922
health aspects (1913) 1913
patients (1892) 1892
thromboembolism - prevention & control (1872) 1872
stroke - etiology (1869) 1869
medical research (1818) 1818
stroke prevention (1806) 1806
bleeding (1805) 1805
prospective studies (1746) 1746
cardiac arrhythmia (1726) 1726
follow-up studies (1719) 1719
medicine & public health (1710) 1710
apixaban (1650) 1650
medicine, experimental (1650) 1650
safety (1634) 1634
antithrombotic therapy (1584) 1584
prothrombin time (1552) 1552
aspirin - therapeutic use (1544) 1544
risk assessment (1537) 1537
heparin - therapeutic use (1450) 1450
dose-response relationship, drug (1446) 1446
oral anticoagulants (1419) 1419
cardiology (1408) 1408
clinical neurology (1397) 1397
heparin (1378) 1378
complications (1331) 1331
usage (1331) 1331
oral anticoagulation (1312) 1312
blood coagulation - drug effects (1310) 1310
fibrillation (1309) 1309
adolescent (1305) 1305
pharmacogenetics (1293) 1293
complications and side effects (1287) 1287
risk-factors (1273) 1273
anticoagulants - pharmacology (1257) 1257
pharmacokinetics (1250) 1250
vitamin k - antagonists & inhibitors (1228) 1228
vitamin k (1198) 1198
drugs (1174) 1174
platelet aggregation inhibitors - therapeutic use (1172) 1172
drug therapy, combination (1171) 1171
incidence (1164) 1164
rats (1151) 1151
thrombin (1145) 1145
internal medicine (1124) 1124
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (39234) 39234
Japanese (721) 721
German (380) 380
Spanish (376) 376
French (369) 369
Russian (244) 244
Portuguese (148) 148
Chinese (128) 128
Czech (97) 97
Italian (91) 91
Swedish (88) 88
Turkish (71) 71
Norwegian (64) 64
Polish (49) 49
Korean (44) 44
Danish (33) 33
Hungarian (26) 26
Finnish (20) 20
Hebrew (18) 18
Slovak (13) 13
Dutch (9) 9
Persian (6) 6
Serbian (6) 6
Croatian (5) 5
Slovenian (5) 5
Bulgarian (4) 4
Afrikaans (3) 3
Romanian (3) 3
Ukrainian (2) 2
Arabic (1) 1
Bosnian (1) 1
Georgian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2011, Volume 365, Issue 10, pp. 883 - 891
In this trial, 14,264 patients with atrial fibrillation were randomly assigned to receive either rivaroxaban or warfarin. In a per-protocol, as-treated... 
NON-INFERIORITY | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | DABIGATRAN | STROKE PREVENTION | PHARMACOKINETICS | EFFICACY | ANTITHROMBOTIC THERAPY | PHARMACODYNAMICS | THROMBOPROPHYLAXIS | ANTICOAGULATION | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Thiophenes - administration & dosage | Warfarin - administration & dosage | Warfarin - therapeutic use | Rivaroxaban | Aged, 80 and over | Female | Stroke - epidemiology | Embolism - epidemiology | Morpholines - adverse effects | Morpholines - therapeutic use | Stroke - prevention & control | Embolism - prevention & control | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Intention to Treat Analysis | Aged | Hemorrhage - chemically induced | Stroke (Disease) | Warfarin | Atrial fibrillation | Patient outcomes | Dosage and administration | Drug therapy | Comparative analysis | Risk factors | Fees & charges | Cardiac arrhythmia | Stroke | Heart attacks | Research & development--R&D | Embolisms | Equity | Equity stake | Hemorrhage | Bleeding | Embolism | Studies | Prevention | Fibrillation | Motivation | Ischemia | Thromboembolism | Drug dosages | Pharmaceuticals | Anticoagulants | Morpholines | Life Sciences | Thiophenes | Atrial Fibrillation
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2018, Volume 319, Issue 12, p. 1278
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 9, pp. 823 - 833
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 15, pp. 1406 - 1415
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 22, pp. 2093 - 2104
Journal Article